D2 Gastrectomy (Surgery)
Treatment for Stomach Cancer
Typical Dosage: Surgical procedure
Effectiveness
90%
Safety Score
25%
Clinical Trials
95
Participants
500K
Comparative Safety Scale(Higher is safer)
Cyanideβ οΈ
Methπ
Cigarettesπ¬
Chemoβ’οΈ
AlcoholπΊ
Morphineπ
Antibioticsπ
Tylenolπ
Exerciseπ
Waterπ§
25
DangerousModerateSafe
Treatment Details
Dosage Range
Surgical procedure
Time to Effect
Immediate (tumor removal)
Treatment Duration
Single procedure + recovery
Evidence Quality
HIGHConfidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$15,000
Side Effect Mgmt:$10,000
Total Annual:$100,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$20,000/QALY
QALYs Gained
8
Outcome-Based Costs
Cost per Remission
$142,857.14
D2 Gastrectomy (Surgery) Outcomes
for Stomach Cancer
Efficacy Outcomes
Overall Effectiveness
+90%
Remission Rate
+70%
Common Side Effects
Dumping syndrome
+30%
Anastomotic leak
+5%
Surgical site infection
+10%
Bleeding
+3%
Malnutrition/Weight loss
+40%
Postoperative pain
+80%
Sources:
Active Clinical Trials
4 active trials recruiting for D2 Gastrectomy (Surgery) in Stomach Cancer
Feasibility and Safety of Robotic Assisted Proximal Gastrectomy With Double-flap Technique for Proximal Early Gastric Cancer
NCT05892289RECRUITINGNA
42 participants
INTERVENTIONAL
Guangzhou, China
Started: Jun 10, 2024
Laparoscopic Proximal Gastrectomy With Double-flap Technique Versus Laparoscopic Total Gastrectomy With Roux-en-Y Reconstruction for Proximal Early Gastric Cancer
NCT05890339NOT YET RECRUITINGNA
216 participants
INTERVENTIONAL
Guangzhou, China
Started: Jun 10, 2023
Upfront Surgery Versus NeoAdjuvant Chemotherapy Followed by Surgery for Resectable Advanced Gastric Cancer: SNAC Study
NCT06472063RECRUITING
684 participants
OBSERVATIONAL
Orbassano, Italy
Started: Sep 22, 2022
the Clinical Efficacy of Robotic and Laparoscopic Radical Total Gastrectomy in Locally Advanced Middle and Upper Gastric Cancer
NCT05235932NOT YET RECRUITINGNA
570 participants
INTERVENTIONAL
Fuzhou, China
Started: Feb 20, 2022
Completed Clinical Trials
8 completed trials for D2 Gastrectomy (Surgery) in Stomach Cancer
Randomized Trial of Adjuvant Chemotherapy With Cisplatin Followed by UFT in Serosa-positive Gastric Cancer (JCOG9206-2)
NCT00147147COMPLETEDPHASE3
280 participants
INTERVENTIONAL
Chuo-ku, Japan
Started: Jan 1, 1993
A Trial of Neoadjuvant TS-1 and Cisplatin for Type 4 and Large Type 3 Gastric Cancer
NCT00252161COMPLETEDPHASE3
316 participants
INTERVENTIONAL
Nagoya,Chikusa-ku,Kanokoden,1-1, Japan +34 more
Started: Nov 1, 2005
Long-term Oncologic Outcomes of Robotic Versus Laparoscopic Total Gastrectomy for Advanced Gastric Cancer
NCT05181306COMPLETED
430 participants
OBSERVATIONAL
Chongqing, China
Started: Oct 1, 2010
Curative D2 vs D1 Lymphadenectomy in Operable Gastric Carcinoma
NCT04340440COMPLETEDNA
80 participants
INTERVENTIONAL
Started: Dec 1, 2014
Robotic and Laparoscopic Total Gastrectomy With D2 Lymphadenectomy for Locally Advanced Gastric Cancer
NCT03500471COMPLETED
142 participants
OBSERVATIONAL
Chongqing, China
Started: Apr 16, 2018
Efficacy of Laparoscopic Subtotal Gastrectomy With D2 Lymph Node Dissection for Locally Advanced Gastric Cancer
NCT01456598COMPLETEDNA
1.05K participants
INTERVENTIONAL
Bucheon-si, South Korea +12 more
Started: Nov 21, 2011
The Predictive Value of Complement C3 in Patients With Advanced Gastric Cancer
NCT02425930COMPLETED
85 participants
OBSERVATIONAL
Guangzhou, China
Started: Aug 1, 2013
Comparison With Open and Totally Laparoscopic Gastrectomy for Gastric Cancer
NCT04481828COMPLETED
60 participants
OBSERVATIONAL
Kocasinan, Turkey (TΓΌrkiye)
Started: Jan 1, 2014
Showing 20 of 97 total trials